Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Phase I Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.

Patients with adequate liver function and performance status in whom liver-directed therapy and capecitabine would be appropriate are eligible for this clinical trial.

Inclusion Criteria:

• Adequate liver function
• Adequate performance status

Exclusion Criteria:

• Significant extrahepatic disease